HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Hemodialysis Catheter Maintains Long-Term Patency

By HospiMedica International staff writers
Posted on 27 Apr 2021
Print article
Image: The Pristine Long-Term Hemodialysis Catheter (Photo courtesy of BD)
Image: The Pristine Long-Term Hemodialysis Catheter (Photo courtesy of BD)
An innovative hemodialysis catheter with a unique lumen design can maintain primary patency rates for up to 180 days.

The BD (Franklin Lakes, NJ, USA) Pristine Long-Term 15.5F hemodialysis catheter boasts a side-hole free symmetric Y-Tip distal lumen, which is aimed to minimize thrombus adhesion (a problem commonly associated with side-hole catheters), facilitate blood clot aspiration prior to hemodialysis, and minimize recirculation rates in both forward and reverse flows. In a prospective feasibility study, which followed 45 patients who received the Pristine Catheter for six months, all catheters were patent at 60-days, and 90.9% remained patent at 180-days post procedure.

“The BD Pristine Catheter adds to our diversified portfolio of products in support of clinicians who care for patients with end stage kidney disease (ESKD) who require hemodialysis,” said Padraic O'Brien, worldwide president of peripheral intervention at BD. “This exciting technology is highly complementary to our current ESKD portfolio, and will enable us to offer a differentiated product that can help to improve the patient experience.”

“A majority of hemodialysis patients in the United States start their treatment with a catheter, and many of those catheter-dependent patients will suffer a catheter-related complication at some point during treatment, which can adversely impact the patient and create additional healthcare system costs,” said Michael Tal, MD, founder of Pristine Access Technologies (Israel), and inventor of the Pristine Catheter. “The Pristine Catheter was designed with hemodialysis patients in mind and to help address some of these concerns.”

While an arteriovenous fistula (AVF) remains the preferred access option for patients on hemodialysis therapy, these often can take four months or longer to mature, and a catheter is often required during this time period; but more than 40% of such patients develop a venous obstruction. Many patients, in fact, prefer a catheter over an AVF, for reasons that include inadequate preparation for dialysis, phobia or avoidance of surgery, or fear of needles (since the connection to the dialysis machine via a catheter does not require needles).

Related Links:
BD

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
1.5T MRI System
uMR 670

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more